Degarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis

Background: Hormone therapy is currently the mainstay in the management of locally advanced and metastatic prostate cancer. We performed a systematic review to compare safety, efficacy and effectiveness of degarelix, a new gonadotropin-releasing hormone (GnRH) antagonist (blocker), versus gonadotrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Seyed Alireza, Rajabi, Fatemeh, Akbari Sari, Ali, Ayati, Mohsen, Heidari, Saeed, Ghamary, Fawzieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898839/
https://www.ncbi.nlm.nih.gov/pubmed/27390687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898839/
https://www.ncbi.nlm.nih.gov/pubmed/27390687

Ejemplares similares